HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ya-Lei Ning Selected Research

Craniocerebral Trauma (Head Injury)

1/2023Knockdown of adenosine A2A receptors in hippocampal neurons prevents post-TBI fear memory retrieval.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ya-Lei Ning Research Topics

Disease

13Traumatic Brain Injuries (Traumatic Brain Injury)
01/2023 - 12/2010
7Brain Injuries (Brain Injury)
08/2023 - 12/2010
7Wounds and Injuries (Trauma)
01/2023 - 04/2011
6Acute Lung Injury
01/2019 - 04/2013
5Neuroinflammatory Diseases
08/2023 - 01/2021
5Cognitive Dysfunction
01/2022 - 11/2013
3Gliosis
01/2023 - 11/2013
3Inflammation (Inflammations)
12/2019 - 04/2011
3Lung Injury
02/2019 - 01/2016
2Blast Injuries
02/2019 - 01/2015
2Cicatrix (Scar)
01/2016 - 04/2011
1Central Nervous System Diseases (CNS Diseases)
08/2023
1Mental Disorders (Mental Disorder)
01/2023
1Craniocerebral Trauma (Head Injury)
01/2023
1Brain Edema (Cerebral Edema)
08/2022
1Tauopathies
01/2021
1Fibrosarcoma
01/2020
1Necrosis
12/2019
1Infections
12/2019
1Pancreatitis
03/2018
1Stroke (Strokes)
01/2017
1Memory Disorders (Memory Loss)
01/2015
1Edema (Dropsy)
11/2013
1Hypertrophic Cicatrix (Hypertrophic Scar)
04/2011

Drug/Important Bio-Agent (IBA)

11Glutamic Acid (Glutamate)FDA Link
08/2022 - 12/2010
8Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
01/2023 - 11/2013
4InflammasomesIBA
08/2023 - 01/2021
4CytokinesIBA
12/2019 - 12/2010
3Proteins (Proteins, Gene)FDA Link
08/2023 - 01/2016
3Adenosine (Adenocard)FDA LinkGeneric
08/2023 - 01/2022
22- (4- (2- carboxyethyl)phenethylamino)- 5'- N- ethylcarboxamidoadenosineIBA
01/2023 - 08/2022
2Neuroprotective AgentsIBA
08/2022 - 01/2015
2HMGB1 Protein (HMG1)IBA
10/2021 - 01/2021
2Interleukin-1beta (Interleukin 1 beta)IBA
12/2019 - 03/2018
2Caffeine (No Doz)FDA LinkGeneric
02/2019 - 01/2015
2Explosive Agents (Explosives)IBA
01/2015 - 11/2013
1NucleotidesIBA
08/2023
1Leucine (L-Leucine)FDA Link
08/2023
1Eosine Yellowish-(YS) (Eosin)IBA
01/2023
1Hematoxylin (Haematoxylon)IBA
01/2023
1ZM 241385 (ZM241385)IBA
01/2023
1Oxaloacetic Acid (Oxalacetic Acid)IBA
08/2022
1N(1)- (6- chloroimidazo(2,1- b)(1,3)thiazole- 5- sulfonyl)tryptamineIBA
01/2022
1Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2022
1Bromodeoxyuridine (BrdU)IBA
01/2020
1Protein Kinase CIBA
12/2019
1LipopolysaccharidesIBA
12/2019
1CoffeeFDA Link
02/2019
1GlucocorticoidsIBA
03/2018
1Chloroquine (Aralen)FDA LinkGeneric
01/2018
1tau Proteins (tau Protein)IBA
01/2017
1GasesIBA
01/2016
1Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2016
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
01/2016
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2016
1Therapeutic UsesIBA
01/2016
1CollagenIBA
04/2011

Therapy/Procedure

1Intravenous Administration
01/2019